Study comparing people with and without bowel inflammation
Part of Digestive system clinical trials.
This study looks at people with inflammatory bowel disease (Crohn’s disease or ulcerative colitis) and compares them with people without it. Researchers want to understand differences that may help explain or better detect the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Be able to give informed consent (you or your family agrees if needed)
- If you have IBD: you must have Crohn’s disease or ulcerative colitis confirmed by tests like endoscopy, scans, and biopsy
- If you are in the comparison (non-IBD) group: you should be having clinic care/endoscopy for a non-IBD stomach or bowel-related reason or screening colonoscopy
- You cannot have been previously diagnosed with inflammatory bowel disease if you are in the non-IBD group
- If you are in the non-IBD group: you should not have a close relative (parent/sibling/child) with IBD
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is looking at how the immune system works in people with inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis. By comparing blood or tissue samples from people with and without IBD, researchers hope to find better ways to treat the disease in the future.
This study collects blood and tissue samples to better understand how the immune system behaves in people with inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis. It aims to advance research rather than test a specific new treatment, and it also enrolls healthy volunteers for comparison.
This study looks at what factors help predict how inflammatory bowel disease (IBD) may progress over time. You may be able to join if you are an adult with IBD and fit one of the study groups based on whether you have used TNF-blocking medicines before.
This study looks at immune system changes in people around the time inflammatory bowel disease (IBD) is first diagnosed, and compares different groups (new, very recent, or not found on scope). It may help researchers understand what the immune system looks like early in IBD and later in people who don’t show it on colonoscopy.
This study looks at how changes in gut bacteria (the microbiome) relate to inflammatory bowel disease, including ulcerative colitis and Crohn disease. It may help researchers understand what might improve symptoms or disease control.
This study looks at blood and/or tissue “molecular” (cell-level) reasons why treatments don’t fully work in adults with Crohn’s disease or ulcerative colitis. If you are starting a biologic or small-molecule medicine and still have moderate to severe symptoms, you may be able to contribute to research that helps improve future care.
Hear when a new Crohn’s disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.